204 related articles for article (PubMed ID: 27844409)
1. Expression of Kallikrein-Related Peptidase 6 in Primary Mucosal Malignant Melanoma of the Head and Neck.
Thierauf J; Veit JA; Lennerz JK; Weissinger SE; Affolter A; Döscher J; Bergmann C; Knopf A; Grünow J; Grünmüller L; Mauch C; Plinkert PK; Hoffmann TK; Hess J
Head Neck Pathol; 2017 Sep; 11(3):314-320. PubMed ID: 27844409
[TBL] [Abstract][Full Text] [Related]
2. Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neck.
Thierauf J; Veit JA; Affolter A; Bergmann C; Grünow J; Laban S; Lennerz JK; Grünmüller L; Mauch C; Plinkert PK; Hess J; Hoffmann TK
Melanoma Res; 2015 Dec; 25(6):503-9. PubMed ID: 26352784
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment outcomes and prognosis of mucosal melanoma of the head and neck: 161 cases from a single institution.
Sun S; Huang X; Gao L; Zhang Y; Luo J; Zhang S; Wang K; Qu Y; Wu R; Liu Q; Xiao J; Xu G; Yi J
Oral Oncol; 2017 Nov; 74():115-122. PubMed ID: 29103739
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes and patterns of failure of head and neck mucosal melanoma treated with multiple treatment modalities.
Xu QQ; Lai YZ; Huang ZL; Zeng ZY; Zhang YN; Ou RY; Wu WM; Chen L; Lu LX
Radiat Oncol; 2021 Jul; 16(1):138. PubMed ID: 34321026
[TBL] [Abstract][Full Text] [Related]
6. Predictors of survival in mucosal melanoma of the head and neck.
Jethanamest D; Vila PM; Sikora AG; Morris LG
Ann Surg Oncol; 2011 Oct; 18(10):2748-56. PubMed ID: 21476106
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM
Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222
[TBL] [Abstract][Full Text] [Related]
8. Primary mucosal melanoma of the head and neck in Denmark, 1982-2012: Demographic and clinical aspects. A retrospective DAHANCA study.
Lawaetz M; Birch-Johansen F; Friis S; Eriksen JG; Kiss K; Gade S; Møller-Madsen M; Pourbordbari N; von Buchwald C
Acta Oncol; 2016 Aug; 55(8):1001-8. PubMed ID: 27031263
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of S100/CD31 and S100/podoplanin double immunostaining in mucosal malignant melanoma of the head and neck.
Wermker K; Brauckmann T; Klein M; Haßfeld S; Schulze HJ; Hallermann C
Head Neck; 2015 Sep; 37(9):1368-74. PubMed ID: 24817089
[TBL] [Abstract][Full Text] [Related]
10. Multicenter Study of Carbon-Ion Radiation Therapy for Mucosal Melanoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN).
Koto M; Demizu Y; Saitoh JI; Suefuji H; Tsuji H; Okimoto T; Ohno T; Shioyama Y; Takagi R; Nemoto K; Nakano T; Kamada T;
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1054-1060. PubMed ID: 28332989
[TBL] [Abstract][Full Text] [Related]
11. Head and neck mucosal malignant melanoma: clinicopathologic correlation with contemporary review of prognostic indicators.
Kerr EH; Hameed O; Lewis JS; Bartolucci AA; Wang D; Said-Al-Naief N
Int J Surg Pathol; 2012 Feb; 20(1):37-46. PubMed ID: 21862490
[TBL] [Abstract][Full Text] [Related]
12. Mucosal melanoma of the head and neck: a population-based study from Slovenia, 1985-2013.
Plavc G; But-Hadžić J; Aničin A; Lanišnik B; Didanović V; Strojan P
Radiat Oncol; 2016 Oct; 11(1):137. PubMed ID: 27737700
[TBL] [Abstract][Full Text] [Related]
13. Mucosal melanoma of the head and neck: a systematic review of the literature.
Lazarev S; Gupta V; Hu K; Harrison LB; Bakst R
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1108-18. PubMed ID: 25539369
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment.
Krenzer S; Peterziel H; Mauch C; Blaber SI; Blaber M; Angel P; Hess J
J Invest Dermatol; 2011 Nov; 131(11):2281-8. PubMed ID: 21753781
[TBL] [Abstract][Full Text] [Related]
15. Ectopic expression of KLK6 in MDA-MB-435 melanoma cells reduces tumorigenicity in vivo.
Pampalakis G; Zingkou E; Zoumpourlis V; Sotiropoulou G
Pathol Res Pract; 2021 Jan; 217():153276. PubMed ID: 33249398
[TBL] [Abstract][Full Text] [Related]
16. Primary mucosal malignant melanoma of the head and neck.
Patel SG; Prasad ML; Escrig M; Singh B; Shaha AR; Kraus DH; Boyle JO; Huvos AG; Busam K; Shah JP
Head Neck; 2002 Mar; 24(3):247-57. PubMed ID: 11891956
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in head and neck mucosal malignant melanoma.
Çomoğlu Ş; Polat B; Çelik M; Şahin B; Enver N; Keleş MN; Sarı ŞÖ
Auris Nasus Larynx; 2018 Feb; 45(1):135-142. PubMed ID: 28385366
[TBL] [Abstract][Full Text] [Related]
18. Survival Outcomes of Mucosal Melanoma in the Head and Neck: Case Series and Review of Current Treatment Guidelines.
Breik O; Sim F; Wong T; Nastri A; Iseli TA; Wiesenfeld D
J Oral Maxillofac Surg; 2016 Sep; 74(9):1859-71. PubMed ID: 27063590
[TBL] [Abstract][Full Text] [Related]
19. Predictors of survival in head and neck mucosal melanoma.
Schmidt MQ; David J; Yoshida EJ; Scher K; Mita A; Shiao SL; Ho AS; Zumsteg ZS
Oral Oncol; 2017 Oct; 73():36-42. PubMed ID: 28939074
[TBL] [Abstract][Full Text] [Related]
20. Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.
Christodoulou S; Alexopoulou DK; Kontos CK; Scorilas A; Papadopoulos IN
Tumour Biol; 2014 May; 35(5):4673-85. PubMed ID: 24430362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
